Ajay Kumar Dhadha - Director at Raphael Pharmaceutical Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Ajay Kumar Dhadha since 02 Aug 2025

Reported holdings for Ajay Kumar Dhadha in Raphael Pharmaceutical Inc.

Form 4 holding Director

Raphael Pharmaceutical Inc.

Security class
Common Stock
Shares / value
403,153
Estimated value
$201,577
Report date
05 Mar 2025
Price
$0.5000
Ownership
By Shanti Gems International Investments Ltd.
Form 4 holding Director

Raphael Pharmaceutical Inc.

Security class
Warrant to purchase Common Stock
Shares / value
250,000
Estimated value
Report date
05 Mar 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Ajay Kumar Dhadha in Raphael Pharmaceutical Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .